Guru Ownership Trend
Guru Analysis for Compass Therapeutics, Inc. (CMPX)
Compass Therapeutics, Inc. (CMPX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.4 M.
Top institutional holders include Chuck Royce and Ken Fisher.
Institutional sentiment is currently Bullish. This is evidenced by a $14.9 M net inflow during the quarter.
Recent activity highlights Chuck Royce who increased their stake by 466.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Compass Therapeutics, Inc. (CMPX)
Major holders include Chuck Royce ($8.57 M), Ken Fisher ($7.13 M), Cliff Asness ($1.06 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 3.26 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $14.9 M, with 4 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in CMPX during the most recent reporting period.
Yes, 2 managers opened new positions in CMPX, and 2 increased their existing holdings. The total reported buy value was $14.9 M.